297
Views
38
CrossRef citations to date
0
Altmetric
Original Research

Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation

, , &
Pages 1155-1166 | Published online: 08 Jun 2011

References

  • FlorenceATJaniPUParticulate delivery: The challenge of the oral routePharmaceutical Particulate CarriersNew YorkMarcel Dekker1993
  • GoldbergMGomez-OrellanaIChallenges for the oral delivery of macromoleculesNat Rev Drug Discov20032428929512669028
  • ShahRBAhsanFKhanMAOral delivery of proteins: Progress and prognosticationCrit Rev Ther Drug Carrier Syst200219213516912197608
  • MorishitaMPeppasNAIs the oral route possible for peptide and protein drug deliveryDrug Discov Today20061119–2090591016997140
  • RadwanMAAboul-EneinHYThe effect of absorption enhancers on the initial degradation kinetics of insulin by α-chymotrypsinInt J Pharm20012171–211112011292547
  • KameiNMarikoMEdaYIdaNNishioRTakayamaKUsefulness of cell-penetrating peptides to improve intestinal insulin absorptionJ Control Release20081321212518727945
  • SonajeKLinKJWangJJSelf-assembled pH-sensitive nanoparticles: A platform for oral delivery of protein drugsAdv Funct Mater2010202136953700
  • MichaelaKMAndreasBSOral peptide drug delivery: Polymer-inhibitor conjugates protecting insulin from enzymatic degradation in vitroBiomaterials200021141499150710872779
  • SimonMBehrensIDaileyLWittmarMKisselTNanosized insulin-complexes based on biodegradable amine-modified graft polyesters poly[vinyl-3-(diethylamino)-propylcarbamate-co-(vinyl acetate)-co-(vinyl alcohol)]-graft-poly(l-lactic acid): Protection against enzymatic degradation, interaction with Caco-2 cell monolayers, peptide transport and cytotoxicityEur J Pharm Biopharm200766216517217150341
  • YinLDingJHeCCuiLTangCYinCDrug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin deliveryBiomaterials200930295691570019615735
  • SonajeKChenYJChenHLEnteric-coated capsules filled with freeze-dried chitosan/poly(gamma-glutamic acid) nanoparticles for oral insulin deliveryBiomaterials201031123384339420149435
  • LinYHSonajeKLinKMMulti-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugsJ Control Release2008132214114918817821
  • MiFLWuYYLinYHOral delivery of peptide drugs using nanoparticles self-assembled by poly(gamma-glutamic acid) and a chitosan derivative functionalized by trimethylationBioconjug Chem20081961248125518517235
  • HashimotoTNomotoMKomatsuKHagaMHayashiMImprovement of intestinal absorption of peptides: Adsorption of B1-Phe monoglucosylated insulin to rat intestinal brush-border membrane vesiclesEur J Pharm Biopharm200050219720410962227
  • GaoYHeLKatsumiHSakaneTFujitaTYamamotoAImprovement of intestinal absorption of insulin and water-soluble macro-molecular compounds by chitosan oligomers in ratsInt J Pharm20083591–2707818450395
  • CuiFDTaoAJCunDMZhangLQShiKPreparation of insulin loaded PLGA-Hp55 nanoparticles for oral deliveryJ Pharm Sci200796242142717051590
  • ThirawongNThongborisuteJTakeuchiHSriamornsakPImproved intestinal absorption of calcitonin by mucoadhesive delivery of novel pectin-liposome nanocomplexesJ Control Release2008125323624518082282
  • SongKHChungSJShimCKEnhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile saltsJ Control Release2005106329830815979756
  • ZhangNPingQNHuangGHXuWFInvestigation of lectin-modified insulin liposomes as carriers for oral administrationInt J Pharm20052941–224725915814248
  • DegimZUnalNEssizDAbbasogluUThe effect of various liposome formulations on insulin penetration across Caco-2 cell monolayerLife Sci200475232819282715464833
  • HanatoJKuriyamaKMizumotoTLiposomal formulations of glucagon-like peptide-1: Improved bioavailability and anti-diabetic effectInt J Pharm20093821–211111619698772
  • ShuklaAKatareOPSinghBVyasSPM-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomesInt J Pharm20103851–2475219835938
  • ConacherMAlexanderJBrewerJMOral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes)Vaccine20011920–222965297411282208
  • SinghPPrabakaranDJainSMishraVJaganathanKSVyasSPCholera toxin B subunit conjugated bile salt stabilized vesicles (bilosomes) for oral immunizationInt J Pharm2004278237939015196642
  • ShuklaAKhatriKGuptaPNGoyalAKMehtaAVyasSPOral immunization against hepatitis B using bile salt stabilized vesicles (bilosomes)J Pharm Pharm Sci2008111596618445364
  • SeniorKBilosomes: The answer to oral vaccine delivery?Drug Discov Today20016201031103211590024
  • SchubertRJaroniHSchoelmerichJSchmidtKHStudies on the mechanism of bile-salt-induced liposomal membrane damageDigestion19832831811906365666
  • SongKHChungSJShimCKPreparation and evaluation of proliposomes containing salmon calcitoninJ Control Release2002841–2273712399165
  • FetihGLindbergSItohKImprovement of absorption enhancing effects of n-dodecyl-beta-D-maltopyranoside by its colon-specific delivery using chitosan capsulesInt J Pharm20052931–212713515778050
  • ShahRBPalamakulaAKhanMACytotoxicity evaluation of enzyme inhibitors and absorption enhancers in Caco-2 cells for oral delivery of salmon calcitoninJ Pharm Sci20049341070108214999743
  • ShaoZLiYKrishnamoorthyRChermakTMitraAKDifferential effects of anionic, cationic, nonionic, and physiologic surfactants on the dissociation, alpha-chymotryptic degradation, and enteral absorption of insulin hexamersPharm Res19931022432518456072
  • YomotaCYoshiiYTakahataTOkadaSSeparation of B-3 monodesaminsulin from human insulin by high-performance liquid chromatography under alkaline conditionsJ Chromatogr A1996721189968653198
  • WeiSJSmithNBImprovements in the preparation of liposomes for electron microscopy and electronspectroscopic imaging (ESI)Microsc Res Tech.19942765575588012058
  • ChenYLuYChenJEnhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile saltInt J Pharm20093761–215316019394416
  • PockerYBiswasSBConformational dynamics of insulin in solution: Circular dichroic studiesBiochemistry19801922504350497006683
  • TiyaboonchaiWWoiszwilloJSimsRCMiddaughCRInsulin containing polyethylenimine-dextran sulfate nanoparticlesInt J Pharm20032551–213915112672610
  • MüllerBKreuterJEnhanced transport of nanoparticle associated drugs through natural and artificial membranes – a general phenomenon?Int J Pharm19991781233210205622
  • PourhosseiniPSSabouryAANajafiFSarboloukiMNInteraction of insulin with a triblock copolymer of PEG-(fumaric-sebacic acids)-PEG: Thermodynamic and spectroscopic studiesBiochim Biophys Acta20071774101274128017881308
  • SadhaleYShahJCStabilization of insulin against agitation-induced aggregation by the GMO cubic phase gelInt J Pharm19991911516410556740
  • KimSKLeeDYLeeEAbsorption study of deoxycholic aid-heparin conjugate as a new form of oral anti-coagulantJ Control Release20071201–241017490773
  • LeeSKimKKumarTSSynthesis and biological properties of insulin-deoxycholic acid chemical conjugatesBioconjug Chem200516361562015898729
  • JohanssonFHjertbergEEirefeltSTrondeAHultkyvistBUMechanisms for absorption enhancement of inhaled insulin by sodium taurocholateEur J Pharm Sci2002171–2637112356421